![Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study | Journal for ImmunoTherapy of Cancer Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study | Journal for ImmunoTherapy of Cancer](https://jitc.bmj.com/content/jitc/9/4/e002292/F1.large.jpg)
Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study | Journal for ImmunoTherapy of Cancer
![A Randomized Controlled 24-Week Trial Evaluating the Safety and Efficacy of Blinded Tapering Versus Continuation of Long-Term Prednisone (5 mg/day) in Patients with Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission A Randomized Controlled 24-Week Trial Evaluating the Safety and Efficacy of Blinded Tapering Versus Continuation of Long-Term Prednisone (5 mg/day) in Patients with Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission](https://acrabstracts.org/wp-content/uploads/2018/10/Paper_76535_abstract_122186_0.jpg)
A Randomized Controlled 24-Week Trial Evaluating the Safety and Efficacy of Blinded Tapering Versus Continuation of Long-Term Prednisone (5 mg/day) in Patients with Rheumatoid Arthritis Who Achieved Low Disease Activity or Remission
![The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients | Pediatric Rheumatology | Full Text The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients | Pediatric Rheumatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12969-019-0326-5/MediaObjects/12969_2019_326_Fig1_HTML.png)
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients | Pediatric Rheumatology | Full Text
![Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations - IOS Press Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations - IOS Press](https://content.iospress.com/media/jnd/2019/6-1/jnd-6-1-jnd180346/jnd-6-jnd180346-g002.jpg)
Management of Adrenal Insufficiency Risk After Long-term Systemic Glucocorticoid Therapy in Duchenne Muscular Dystrophy: Clinical Practice Recommendations - IOS Press
![Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation | The BMJ Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation | The BMJ](https://www.bmj.com/content/bmj/365/bmj.l1800/F1.medium.jpg)
Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation | The BMJ
![Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial - The Lancet Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/43615203-ecc2-4753-b974-91bf18a7454c/gr1_lrg.jpg)
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial - The Lancet
![Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children - ScienceDirect Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253820312321-fx1.jpg)
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children - ScienceDirect
![Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. - Abstract - Europe PMC Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7871208/bin/jamaneurol-e205407-g001.jpg)
Comparison of Corticosteroid Tapering Regimens in Myasthenia Gravis: A Randomized Clinical Trial. - Abstract - Europe PMC
![Prednisone or prednisolone tapering scheme [once-daily administration]. | Download Scientific Diagram Prednisone or prednisolone tapering scheme [once-daily administration]. | Download Scientific Diagram](https://www.researchgate.net/publication/344536978/figure/tbl1/AS:944242050482177@1602136256174/Prednisone-or-prednisolone-tapering-scheme-once-daily-administration.png)
Prednisone or prednisolone tapering scheme [once-daily administration]. | Download Scientific Diagram
![Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial | European Respiratory Society Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial | European Respiratory Society](https://openres.ersjournals.com/content/erjor/5/3/00009-2019/F2.large.jpg)
Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial | European Respiratory Society
![Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression: Molecular Therapy - Methods & Clinical Development Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/2238217c-299c-43df-8a45-44f298728f48/fx1_lrg.jpg)
Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression: Molecular Therapy - Methods & Clinical Development
![Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial | European Respiratory Society Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial | European Respiratory Society](https://openres.ersjournals.com/content/erjor/5/3/00009-2019/F1.large.jpg)